Digoxin, in a common clinical dose and at a low serum level, brought out severe manifestations of sinus node dysfunction in a patient who had previously undergone successful mitral valve replacement. This report presents the results of extensive clinical and electrophysiologic studies of this patient before and after a digoxin challenge. In the absence of cardiac glycoside, the only demonstrable abnormalities of sinus node function were mild resting sinus bradyeardia and failure to respond to atropine administration. Responses to isoproterenol administration, programmed premature atrial stimulation, and overdrive pacing at several cycle lengths were normal. Following the administration of intravenous digoxin, 1.025 mg/24 hrs, the resting sinus cycle length increased and the response to overdrive pacing becarne markedly abnormal. The latter was followed by sinus pauses Received November 25, 1974; revision accepted for publication February 6, 1975. 162 concentrations remain to be established. Digitalis, an agent known to have some negative chronotropic effects in many patients, has been reported to be well tolerated in patients with sinus node dysfunction.9 However, findings in groups of patients do not always relate to individual patients. This report demonstrates a severe toxic effect of a moderate dose of digoxin in a patient with the syndrome of sinus node dysfunction.
concentrations remain to be established. Digitalis, an agent known to have some negative chronotropic effects in many patients, has been reported to be well tolerated in patients with sinus node dysfunction. 9 However, findings in groups of patients do not always relate to individual patients. This report demonstrates a severe toxic effect of a moderate dose of digoxin in a patient with the syndrome of sinus node dysfunction.
Case History R. L., a 53-year-old American Indian, had mitral valve replacement for isolated mitral regurgitation due to mitral valve prolapse in May, 1972 . Although his symptoms of congestive heart failure were relieved by mitral valve replacement, he was maintained on digoxin 0.25 mg/day, postoperatively. During four months of preoperative observation, heart rates ranged between 50 and 60 beats/min. The patient was receiving digoxin 0.25 mg/day during part of this period. Maximum treadmill exercise at this time increased heart rate to only 105 beats/min.
In April, 1973 , the patient complained of orthostatic lightheadedness. An electrocardiogram demonstrated sinus bradyeardia at a rate of 40 beats/min. A nonspecific intraventricular conduction delay was present. There were nonspecific ST-T wave changes that were compatible with digitalis effect.
Circulation, Volume 52, July 1975 Digoxin was discontinued and he was hospitalized and monitored. The patient had a history of chronic cough with sputum production. Pulmonary function tests were performed during the previous year. The vital capacity was 4.3 L/min, forced expired volume (1 sec) was 1.55 L/min and maximum mid-expiratory flow was 0.43 L/min. There was no evidence of myxedema. Physical examination showed a thin Indian male in no acute distress with a pulse of 45 beats/min, blood pressure of 125/80, and respiratory rate of 18/min. Cardiovascular examination was unremarkable save for the slow rate and prosthetic valve sounds. Expiratory rhonchi were heard throughout both lung fields. Routine blood chemistries, including electrolytes, were normal. Serum creatinine was 0.8 mg/100 ml. BUN was 14 mg/100 ml. Hemogram and serum LDH were compatible with a mild hemolytic anemia. Serum digoxin was 0.2 ng/ml. Chest X-ray showed low diaphragms and bullous changes in the right lung field. Vectorcardiogram showed terminal superior forces. The mean frontal plane QRS axis was +300. Continuous electrocardiographic monitoring demonstrated heart rates ranging from 35 to 60 beats/min. The rhythm remained sinus bradyeardia. On several occasions sinus pauses in excess of 2.5 sec were noted. There were no episodes of tachyarrhythmia. Five days after admission the patient underwent a three-day protocol of electrophysiologic study.
Electrophysiologic Protocol Informed consent was obtained and all studies were performed in the resting nonsedated, postabsorptive state. On day 1, rate and rhythm were determined from the surface ECG recorded during a 15 minute control period, and during and after infusion of isoproterenol. Isoproterenol infusion rates were increased in 0.005 mcg/kg/min increments every 5 min until an infusion rate of 0.04 mcg/kg/min was achieved. Rate was determined from records obtained during the last minute of the control period and during the last minute of each infusion period. Isoproterenol infusion was then discontinued. After the heart rate returned to the control state, four doses of atropine sulfate 0.005 mg/kg were given at 5 min intervals. Heart rate was determined from records obtained during the last minute of the control period and during the last minute of each infusion period.
On day 2, under fluoroscopic control, a #6F quadripolar electrode catheter was inserted via an antecubital vein and positioned in the right atrium such that the proximal electrode pair was at the junction of the right atrium and superior vena cava. The proximal electrode pair was used to pace the atrium. The distal pair was used to record the high right atrial electrogram. A #6F tripolar electrode catheter was inserted via the right femoral vein and positioned across the tricuspid valve for recording of the His bundle electrogram. Signals from the atrial and His bundle electrodes were simultaneously recorded with the body surface ECG.
These signals, along with one second time marks, were simultaneously displayed on a Hewlett-Packard multichannel oscillograph and recorded on FM magnetic tape at 33/4 inches per second. Records for analysis were obtained by playback to an Elema Mingograf 800 Recorder at paper speeds of 100 and 200 mm/sec. All intervals were measured using a Science Accessories Corporation graf/pen connected to a Digital Equipment corporation PDP-11 computer.
Control recordings of spontaneous sinus rhythm were obtained for a period of 15 minutes. Thereafter, premature atrial stimuli were introduced via the stimulating electrode pair during spontaneous sinus rhythm. The atrial elecCirculation, Volume 52, July 1975 trogram was used to initiate a programmable stimulator. In this way, atrial premature stimuli -2-2.5 X diastolic threshold, 2 msec in duration -were introduced via an isolation transformer after every sixth spontaneous sinus cycle. Stimuli were introduced late in atrial diastole and moved progressively earlier in 5-10 msec increments until the entire diastolic period was scanned. Refractory periods were measured during spontaneous sinus rhythm. Overdrive atrial pacing was then performed at various cycle lengths, ranging from 1000-353 msec. Control cycle lengths were obtained during a 5 min period before overdrive was begun. Pacing at each cycle length was continued one minute. Following cessation of pacing, the first 20 cycles were recorded. At completion of the day 2 study, the His bundle catheter was removed and the quadripolar catheter was left in place.
Between days 2 and 3 the patient was given intravenous digoxin. A total dose of 1.025 mg (0.02 mg/kg) was administered in five divided doses over a 24-hour period. The last dose (0.125 mg) was administered two hours prior to electrophysiologic study.
On day 3, control recording, premature atrial stimulation, and overdrive pacing were repeated in a manner identical to that of day 2. Following this, atropine sulfate was administered in four aliquots of 0.005 mg/kg and the effects on heart rate and escape cycles following overdrive pacing were observed. Isoproterenol was then administered intravenously at incremental infusion rates until a maximum infusion rate of 0.04 mcg/kg/min was achieved. The effects on heart rate and escape cycles following overdrive pacing were observed. At completion of the protocol, the atrial pacing catheter was left in place an additional 18 hours.
Results of Electrophysiologic Study
Days 1 and 2 (Control)
During both study days, the patient manifested a consistent sinus bradyeardia. On day 1, the mean cycle length was 1317 msec (table 1) . In response to a graded infusion of isoproterenol, the mean cycle length decreased to 546 msec at an infusion rate of 2 mcg/min (table 1) . Atropine, 0.02 mg/kg, had no significant effect on heart rate (table 1).
On day 2, the mean value of the A-A interval was 1193 ± 14.0 msec (N = 10); A-H interval was 138 + 3.9 msec (N = 10); H-V interval 45 + 4.4 msec (N = 10). The P wave duration was 94 + 4.2 msec (N = 10), and the QRS complex duration was 118 ± 4.5 msec (N = 10). The QRS configuration was compatible with a nonspecific incomplete intraventricular conduction delay. The functional refractory period (FRP) of the atrioventricular node (AVN) was 425 msec at a basic cycle length of 1187 msec. The FRP of the His-Purkinje system was 550 msec at a basic cycle length of 1262 msec. The effective refractory period (ERP) of the AVN was 420 msec at a basic cycle length of 1225 msec. The ERP of the HisPurkinje system was 478 msec at a basic cycle length of 1198 msec.
The effect of premature atrial stimulation is shown in the left hand panel of figure 1 . The return and post [13] [14] [15] In summary, the only abnormalities which could be demonstrated by this extensive electrophysiologic study were sinus bradycardia, "sinus pauses" induced by overdrive, and a failure to respond to atropine administration.
On day 3 (following administration of digoxin, 1.025 mg, over 24 hr), the mean sinus cycle length was 1341 msec (45 beats/min). This was not appreciably different than the control cycle length recorded on day 1. The response to premature atrial stimulation is shown in the right hand panel of figure 1 . The Zone I return cycle lengths were similar to those recorded under control conditions. Sinus pauses ranging between 2282 and 3500 msec were noted on five different occasions during the period of premature atrial stimulation. The FRP of the atrioventricular conduction system was 588 msec at a basic cycle length of 1296 msec. The ERP of the atrioventricular conduction system was 525 msec at a basic cycle length of 1251 msec.
Overdrive suppression, on day 3, demonstrated marked abnormalities that were not present on day 2. Figure 3 demonstrates the response to overdrive suppression at a pacing cycle length of 545 msec under control conditions (day 2) and following digoxin (day 3). The escape cycles which were unremarkable under control conditions were dramatically altered on day 3. The first, second, seventh, and ninth cycles were 4748, 4822, 3015, and 2818 msec, respectively. These values are approximately whole number multiples of the third, eighth, and tenth cycles. A more dramatic response is seen in figure 4 , in which a 6030 msec pause (second cycle) was recorded on day 3. During this pause the patient complained of slight drowsiness. Figure 5 shows a similar marked prolongation of the sinus escape cycles after pacing at a cycle length of 462 msec. The prolonged sinus pauses persisted for as long as 20 cycles following termination of pacing ( fig.  3 ). The patient did not have any symptoms during these pauses, as a slow A-V junctional escape rhythm without atrial capture occurred concurrently with the abnormal sinus rhythm.
Pauses were seen at pacing cycles as long as 1000 msec. The pauses seen were compatible with sinoatrial exit block.
Atropine, 0.02 mg/kg, was given and no effect on spontaneous sinus cycle length was noted (table 1) . The FRP of the atrioventricular conduction system decreased to 540 msec at a basic sinus cycle length of 1338 msec. The response to overdrive suppression was not appreciably altered by atropine ( fig. 4 ) at pacing cycle lengths ranging between 545 and 1200 msec. Infusion of graded doses of isoproterenol resulted in a decrease in cycle length to a mean value that was comparable with that seen under control conditions. But at each of the three lower infusion rates the mean value of the cycle length was consistently more than that obtained under control conditions (table 1) . The abnormal response to rapid atrial pacing following digoxin was completely reversed following exposure to isoproterenol, 2.0 mcg/min ( fig. 5 ). The effects of atropine and isoproterenol on the post-digoxin response to overdrive were consistent at all pacing cycle lengths.
Subsequent Course
Digoxin therapy was discontinued. It was decided not to implant a permanent pacemaker in this patient. He was discharged on warfarin sodium and was instructed to take no other medication. He had no cardiovascular symptoms during the next eleven months. Orthostatic lightheadedness was no longer present. In March, 1974, he began experiencing frequent episodes of rapid irregular palpitations which would abate spontaneously. Later in March, the patient ex- This patient presented with clinical evidence of sick sinus syndrome -manifested by sinus bradyeardia, a blunted chronotropic response to exercise, spontaneous sinus pauses, and symptoms which could be attributed to bradyarrhythmia. He was on a common maintenance dose of digoxin at the time. During electrophysiologic study in the absence of any digitalis glycoside no definite abnormality of sinus node function could be elicited -even with provocative pacing techniques. Following the administration of only a moderate amount of digoxin, overdrive pacing elicited a strikingly abnormal response. The patient was discharged off digitalis with apparent clinical improvement. This improvement, however, was only temporary. Symptoms returned in less than a year and led to the patient's untimely death. Whether this clinical deterioration was due to the consequences of sick sinus syndrome and whether it could have been prevented by a prophylactic pacemaker is a matter of speculation.
Mechanism of Digitalis Toxicity in Sick Sinus Syndrome
Because digitalis acts not only upon heart muscle but also upon peripheral smooth muscle and the nervous system,16-23 it is sometimes difficult to delineate the pharmacologic and toxic actions of the drug on isolated functions. The effect of digitalis glycosides on heart rate have been shown to be mediated through direct effects on sinus automaticity, control of cardiac decompensation, and effects mediated through autonomic pathways."1621 Most commonly, slowing of the sinus rate following digitalis administration results from the control of congestive heart failure. When usual clinical doses of digitalis are administered to normal man, there is little if any change in sinus rate.22 Relatively large doses of digitalis administered to experimental animals do tend to cause sinus slowing. '6-20, 22 However, this effect appears to be mediated predominantly through the autonomic nervous system. 6, 19, 21, 22 These autonomic effects appear to include both enhancement of vagal tone16 19, [21] [22] [23] and antagonism of adrenergic input. '16 19, 21-23 In this patient part of the effect of digitalis on sinus node function appeared to have been mediated through the autonomic nervous system. The long sinus pauses induced by overdrive pacing in the presence of digoxin were only slightly shortened by atropine. However, atropine may have a paradoxical effect on sinus pauses following rapid atrial pacing in some patients with sinus node dysfunction,24 and the Circulation, Volume 52, July 1975 effects obtained in our patient are difficult to interpret in that light. The additional infusion of isoproterenol entirely reversed the abnormalities caused by digoxin. Isoproterenol's rather dramatic effect in reversing these abnormalities suggests that it may improve depressed conduction as well as increase automaticity. However, at the time of administration of isoproterenol, therapeutic doses of atropine had already been given. It is possible that this complete reversal of digitalis toxicity might have occurred only in the presence of both isoproterenol and atropine.
The mechanism of sinus node dysfunction in this patient is uncertain. The extremely long pauses suggest a possible role for sinoatrial block. In the middle panel of figure 5 the cycle lengths for beats 1, 2 and 5 are, respectively, four times, four times, and two times the value of the third and sixth cycles. This lends additional credence to the possibility of an exit block mechanism. The long pauses illustrated in figure 2 are compatible with 5:3 exit block. Pauses which occurred spontaneously during the period of premature atrial stimulation were also seen. Whether these long pauses reflected the sinoatrial block that has been associated with digitalis toxicity25-27 or subthreshold oscillations in sinoatrial node transmembrane potentials28 or disturbance of pacemaker current29 is unknown. It is of interest that the results obtained using the premature atrial stimulation technique do not suggest a markedly prolonged sinoatrial conduction time.
Meaning of Electrophysiologic Findings
Because access to the sinoatrial node, particularly in man, is impossible, any method used to study sinus node function is of necessity inferential. Until recently, delineation of disorders of sinus node function in man has been limited to deductive analysis of the surface electrocardiogram. During Overdrive pacing, which has been shown to suppress cardiac pacemaking tissue,30 has been advocated as a means of provoking sinus dysfunction in patients with sick sinus syndrome.13-15 Following overdrive pacing, normal subjects respond with a moderate prolongation of the spontaneous sinus cycle length, followed by a brief "warm-up"' resulting in progressively shorter cycle lengths, and then continue at their previous sinus rate. 13 . The usual response to overdrive in sick sinus syndrome is a marked prolongation of the initial spontaneous sinus cycle, followed by a prolonged warm-up period, and finally the resumption of the previous sinus rate. Unfor Although extraordinarily useful in the treatment of a myriad of cardiac disorders, digitalis preparations have been demonstrated to cause many different toxic symptoms and signs, some of which can be serious or lethal. Clinicians must be constantly aware of possible toxic manifestations of this drug. Serum digoxin levels may be useful in defining a setting in which toxicity is likely to occur, but toxic manifestations may occur even at serum concentrations well within the therapeutic range. This was true with this patient.
The experience of other authors9 suggests that there is no absolute contraindication to digitalis therapy in patients with sick sinus syndrome. However, it is evident that even small amounts of this agent may be extremely toxic for selected patients. Digitalis preparations should be used with caution in patients with sick sinus syndrome. When such patients must be treated, it is prudent to observe them carefully with continuous electrocardiographic monitoring in the presence of full therapeutic drug levels. If there is any evidence that digitalis provokes the manifestations of sick sinus syndrome and its continued usage is mandatory, then prophylactic permanent pacemaker therapy should be considered. 
